PRESS RELEASE published on 10/10/2024 at 12:22, 1 year 5 months ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
BRIEF published on 10/01/2024 at 13:41, 1 year 5 months ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 1 year 5 months ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
BRIEF published on 09/17/2024 at 10:27, 1 year 6 months ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 1 year 6 months ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:22, 1 year 6 months ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 1 year 6 months ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 08/22/2024 at 12:52, 1 year 7 months ago Successful VAT recovery for Novacyt Financial Health Regulation Novacyt VAT Recovered DHSC Dispute
BRIEF published on 08/22/2024 at 12:49, 1 year 7 months ago Successful VAT reclaim of £12.2 million by Novacyt Financial Settlement Diagnostics Novacyt VAT Reclaim HMRC
PRESS RELEASE published on 08/22/2024 at 12:44, 1 year 7 months ago Successful VAT reclaim of £12.2 million Novacyt successfully reclaims £12.2 million in VAT from HMRC, increasing net cash position by over £7.0 million. Inside information disclosed Inside Information Novacyt VAT Reclaim Net Cash Position HMRC
Published on 03/26/2026 at 04:55, 1 hour 28 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 5 hours 43 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 5 hours 53 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 11 hours 8 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 16 hours 53 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/26/2026 at 06:06, 17 minutes ago Bajaj Mobility AG Annual Financial Report 2025: Successful Turnaround Following an Intensive Year of Restructuring – Operational Stabilization and Record Motorsport Season
Published on 03/26/2026 at 06:00, 22 minutes ago Bajaj Mobility AG confirms revenue and earnings for 2025 and publishes the annual report 2025
Published on 03/26/2026 at 04:45, 1 hour 38 minutes ago Powering global maritime decarbonization, Shanghai Electric delivers first large-scale biomethanol bunkering for international shipping
Published on 03/26/2026 at 01:05, 5 hours 18 minutes ago Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference
Published on 03/25/2026 at 20:00, 10 hours 23 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 18:31, 11 hours 52 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 12 hours 38 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
